Clinical and prognostic heterogeneity of C and D GOLD groups

Eur Respir J. 2015 Jul;46(1):250-4. doi: 10.1183/09031936.00012215.

¹ Thorax Institute, Hospital Clinic, IDIBAPS, University of Barcelona and CIBER Enfermedades Respiratorias (CIBERES), Barcelona, Spain alvar.agusti@clinic.ub.es.
² Dept of Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
³ Clinical Statistics, GlaxoSmithKline R&D, Research Triangle Park, NC, USA.
⁴ ELEGI Labs, University of Edinburgh, Edinburgh, UK.
⁵ Dept of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
⁶ Respiratory Therapy Area Unit, GlaxoSmithKline R&D, King of Prussia, PA, USA.
⁷ Worldwide Epidemiology, GlaxoSmithKline R&D, Uxbridge, England.
⁸ Dept of Respiratory Medicine, Brigham and Women's Hospital, Boston, MA, USA.

No abstract available

Publication types